Tissue engineering for pulmonary diseases: Insights from the laboratory

Respirology

Volumn 17, Issue 3, 2012, Pages 445-454

  Kubo, Hiroshi ^a  

^a TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

chronic obstructive pulmonary disease; progenitor cells; scaffold; stem cells; tissue engineering

Indexed keywords

3 [(3 CHOLAMIDOPROPYL)DIMETHYLAMMONIO] 1 PROPANESULFONIC ACID; COLLAGEN TYPE 1; COLLAGEN TYPE 3; COLLAGEN TYPE 4; COLLAGEN TYPE 5; DODECYL SULFATE SODIUM; FIBRONECTIN; GELATIN; GELFOAM; GRANULOCYTE COLONY STIMULATING FACTOR; GREEN FLUORESCENT PROTEIN; INTEGRIN; KALININ; METALLOPROTEINASE; SCLEROPROTEIN; STEM CELL FACTOR RECEPTOR; TISSUE SCAFFOLD;

ADULT RESPIRATORY DISTRESS SYNDROME; ALLOTRANSPLANTATION; B LYMPHOCYTE; BASEMENT MEMBRANE; CANCER STEM CELL; CARTILAGE CELL; CELL ADHESION; CELL DIFFERENTIATION; CELL ISOLATION; CELL POPULATION; CELL PROLIFERATION; CELL STRUCTURE; CLINICAL TRIAL (TOPIC); DENDRITIC CELL; DRUG SCREENING; EMBRYONIC STEM CELL; EPITHELIUM CELL; EXTRACELLULAR MATRIX; HUMAN; IMMUNE RESPONSE; IN VIVO STUDY; INTROSPECTION; LABORATORY DIAGNOSIS; LAMELLAR BODY; LUNG ALVEOLUS CELL; LUNG ALVEOLUS EPITHELIUM; LUNG CANCER; LUNG DISEASE; LUNG EDEMA; LUNG FUNCTION; LUNG INJURY; LUNG PARENCHYMA; LUNG PERFUSION; LUNG VENTILATION; MACROPHAGE; MESENCHYMAL STEM CELL; MESENCHYME; MICROARRAY ANALYSIS; MORTALITY; NONHUMAN; PERICYTE; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; REVIEW; STEM CELL; TISSUE ENGINEERING; VASCULARIZATION; XENOGRAFT;

ANIMALS; EXTRACELLULAR MATRIX PROTEINS; HUMANS; LUNG; LUNG DISEASES; MICE; PROTO-ONCOGENE PROTEINS C-KIT; RATS; STEM CELLS; TISSUE ENGINEERING; TISSUE SCAFFOLDS;

EID: 84859030942     PISSN: 13237799     EISSN: 14401843     Source Type: Journal    
DOI: 10.1111/j.1440-1843.2012.02145.x     Document Type: Review

References (106)

1. Takahashi K, Yamanaka S,. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006; 126: 663-76.
2. Kriks S, Shim JW, Piao J, et al,. Dopamine neurons derived from human ES cells efficiently engraft in animal models of Parkinson's disease. Nature 2011; 480: 547-51.
3. Yusa K, Rashid ST, Strick-Marchand H, et al,. Targeted gene correction of alpha1-antitrypsin deficiency in induced pluripotent stem cells. Nature 2011; 478: 391-4.
4. Abdel-Latif A, Bolli R, Tleyjeh IM, et al,. Adult bone marrow-derived cells for cardiac repair: a systematic review and meta-analysis. Arch. Intern. Med. 2007; 167: 989-97.
5. Traverse JH, Henry TD, Ellis SG, et al,. Effect of intracoronary delivery of autologous bone marrow mononuclear cells 2 to 3 weeks following acute myocardial infarction on left ventricular function: the LateTIME randomized trial. JAMA 2011; 306: 2110-19.
6. Bolli R, Chugh AR, D'Amario D, et al,. Cardiac stem cells in patients with ischaemic cardiomyopathy (SCIPIO): initial results of a randomised phase 1 trial. Lancet 2011; 378: 1847-57.
7. Omori K, Nakamura T, Kanemaru S, et al,. Regenerative medicine of the trachea: the first human case. Ann. Otol. Rhinol. Laryngol. 2005; 114: 429-33.
8. Macchiarini P, Jungebluth P, Go T, et al,. Clinical transplantation of a tissue-engineered airway. Lancet 2008; 372: 2023-30.
9. Kalathur M, Baiguera S, Macchiarini P,. Translating tissue-engineered tracheal replacement from bench to bedside. Cell. Mol. Life Sci. 2010; 67: 4185-96.
10. Nakamura T, Ohmori K, Kanemaru S,. Tissue-engineered airway and 'in situ tissue engineering'. Gen. Thorac. Cardiovasc. Surg. 2011; 59: 91-7.
11. Baiguera S, Birchall MA, Macchiarini P,. Tissue-engineered tracheal transplantation. Transplantation 2010; 89: 485-91.
12. Fujino N, Kubo H, Suzuki T, et al,. Isolation of alveolar epithelial type II progenitor cells from adult human lungs. Lab. Invest. 2011; 91: 363-78.
13. Hermanns MI, Unger RE, Kehe K, et al,. Lung epithelial cell lines in coculture with human pulmonary microvascular endothelial cells: development of an alveolo-capillary barrier in vitro. Lab. Invest. 2004; 84: 736-52.
14. Hoganson DM, Pryor HI, Vacanti JP,. Tissue engineering and organ structure: a vascularized approach to liver and lung. Pediatr. Res. 2008; 63: 520-6.
15. Huh D, Matthews BD, Mammoto A, et al,. Reconstituting organ-level lung functions on a chip. Science 2010; 328: 1662-8.
16. Nalayanda DD, Wang Q, Fulton WB, et al,. Engineering an artificial alveolar-capillary membrane: a novel continuously perfused model within microchannels. J. Pediatr. Surg. 2010; 45: 45-51.
17. Hoganson DM, Pryor HI, Bassett EK, et al,. Lung assist device technology with physiologic blood flow developed on a tissue engineered scaffold platform. Lab Chip 2011; 11: 700-7.
18. Lehmann AD, Daum N, Bur M, et al,. An in vitro triple cell co-culture model with primary cells mimicking the human alveolar epithelial barrier. Eur. J. Pharm. Biopharm. 2011; 77: 398-406.
19. Lin Y-M, Zhang A, Rippon HJ, et al,. Tissue engineering of lung: the effect of extracellular matrix on the differentiation of embryonic stem cells to pneumocytes. Tissue Eng. Part A 2010; 16: 1515-26.
20. Daley WP, Peters SB, Larsen M,. Extracellular matrix dynamics in development and regenerative medicine. J. Cell Sci. 2008; 121: 255-64.
21. Dunsmore SE, Rannels DE,. Extracellular matrix biology in the lung. Am. J. Physiol. Lung Cell. Mol. Physiol. 1996; 270: L3-27.
22. van der Rest M, Garrone R,. Collagen family of proteins. FASEB J. 1991; 5: 2814-23.
23. Belvisi MG, Bottomley KM,. The role of matrix metalloproteinases (MMPs) in the pathophysiology of chronic obstructive pulmonary disease (COPD): a therapeutic role for inhibitors of MMPs? Inflamm. Res. 2003; 52: 95-100.
24. Tzu J, Marinkovich MP,. Bridging structure with function: structural, regulatory, and developmental role of laminins. Int. J. Biochem. Cell Biol. 2008; 40: 199-214.
25. Katayama M, Ishizaka A, Sakamoto M, et al,. Laminin gamma2 fragments are increased in the circulation of patients with early phase acute lung injury. Intensive Care Med. 2010; 36: 479-86.
26. Lin YM, Zhang A, Rippon HJ, et al,. Tissue engineering of lung: the effect of extracellular matrix on the differentiation of embryonic stem cells to pneumocytes. Tissue Eng. Part A 2010; 16: 1515-26.
27. Ota C, Fujino N, Suzuki T, et al,. A novel differentiation assay system for human alveolar epithelial type II cells from alveolar epithelial stem/progenitor cells in vitro. Am. J. Respir. Crit. Care Med. 2011; 183: A3516.
28. Ruoslahti E,. Fibronectin and its receptors. Annu. Rev. Biochem. 1988; 57: 375-413.
29. Geiser T, Jarreau PH, Atabai K, et al,. Interleukin-1beta augments in vitro alveolar epithelial repair. Am. J. Physiol. Lung Cell. Mol. Physiol. 2000; 279: L1184-90.
30. Petersen TH, Calle EA, Niklason LE,. Strategies for lung regeneration. Mater. Today 2011; 14: 196-201.
31. Pedersen PS, Frederiksen O, Holstein-Rathlou N-H, et al,. Ion transport in epithelial spheroids derived from human airway cells. Am. J. Physiol. Lung Cell. Mol. Physiol. 1999; 276: L75-L80.
32. Liu M, Skinner SJ, Xu J, et al,. Stimulation of fetal rat lung cell proliferation in vitro by mechanical stretch. Am. J. Physiol. 1992; 263: L376-83.
33. Andrade CF, Wong AP, Waddell TK, et al,. Cell-based tissue engineering for lung regeneration. Am. J. Physiol. Lung Cell. Mol. Physiol. 2007; 292: L510-18.
34. Lavik E, Langer R,. Tissue engineering: current state and perspectives. Appl. Microbiol. Biotechnol. 2004; 65: 1-8.
35. Cortiella J, Nichols JE, Kojima K, et al,. Tissue-engineered lung: an in vivo and in vitro comparison of polyglycolic acid and pluronic F-127 hydrogel/somatic lung progenitor cell constructs to support tissue growth. Tissue Eng. 2006; 12: 1213-25.
36. Franzdõttir SR, Axelsson IT, Arason AJ, et al,. Airway branching morphogenesis in three dimensional culture. Respir. Res. 2010; 11: 162.
37. Ott HC, Matthiesen TS, Goh SK, et al,. Perfusion-decellularized matrix: using nature's platform to engineer a bioartificial heart. Nat. Med. 2008; 14: 213-21.
38. Ross EA, Williams MJ, Hamazaki T, et al,. Embryonic stem cells proliferate and differentiate when seeded into kidney scaffolds. J. Am. Soc. Nephrol. 2009; 20: 2338-47.
39. Uygun BE, Soto-Gutierrez A, Yagi H, et al,. Organ reengineering through development of a transplantable recellularized liver graft using decellularized liver matrix. Nat. Med. 2010; 16: 814-20.
40. Badylak SF, Taylor D, Uygun K,. Whole-organ tissue engineering: decellularization and recellularization of three-dimensional matrix scaffolds. Annu. Rev. Biomed. Eng. 2011; 13: 27-53.
41. Calle EA, Petersen TH, Niklason LE,. Procedure for lung engineering. J. Vis. Exp. 2011; 49: e2651.
42. Petersen TH, Calle EA, Zhao L, et al,. Tissue-engineered lungs for in vivo implantation. Science 2010; 329: 538-41.
43. Ott HC, Clippinger B, Conrad C, et al,. Regeneration and orthotopic transplantation of a bioartificial lung. Nat. Med. 2010; 16: 927-33.
44. Daly AB, Wallis JM, Borg ZD, et al,. Initial binding and recellularization of decellularized mouse lung scaffolds with bone marrow-derived mesenchymal stromal cells. Tissue Eng. Part A 2012; 18: 1-16.
45. Petersen TH, Calle EA, Colehour MB, et al,. Matrix composition and mechanics of decellularized lung scaffolds. Cells Tissues Organs 2012; 195: 222-31.
46. Song JJ, Kim SS, Liu Z, et al,. Enhanced in vivo function of bioartificial lungs in rats. Ann. Thorac. Surg. 2011; 92: 998-1006.
47. Hammerman MR,. Tissue engineering the kidney. Kidney Int. 2003; 63: 1195-204.
48. Yokoo T, Fukui A, Ohashi T, et al,. Xenobiotic kidney organogenesis from human mesenchymal stem cells using a growing rodent embryo. J. Am. Soc. Nephrol. 2006; 17: 1026-34.
49. Ishizawa K, Kubo H, Yamada M, et al,. Hepatocyte growth factor induces angiogenesis in injured lungs through mobilizing endothelial progenitor cells. Biochem. Biophys. Res. Commun. 2004; 324: 276-80.
50. Hegab AE, Kubo H, Yamaya M, et al,. Intranasal HGF administration ameliorates the physiologic and morphologic changes in lung emphysema. Mol. Ther. 2008; 16: 1417-26.
51. Ishizawa K, Kubo H, Yamada M, et al,. Bone marrow-derived cells contribute to lung regeneration after elastase-induced pulmonary emphysema. FEBS Lett. 2004; 556: 249-52.
52. Murakami S, Nagaya N, Itoh T, et al,. Adrenomedullin regenerates alveoli and vasculature in elastase-induced pulmonary emphysema in mice. Am. J. Respir. Crit. Care Med. 2005; 172: 581-9.
53. Nolen-Walston RD, Kim CF, Mazan MR, et al,. Cellular kinetics and modeling of bronchioalveolar stem cell response during lung regeneration. Am. J. Physiol. Lung Cell. Mol. Physiol. 2008; 294: L1158-65.
54. Kim CF, Jackson EL, Woolfenden AE, et al,. Identification of bronchioalveolar stem cells in normal lung and lung cancer. Cell 2005; 121: 823-35.
55. McQualter JL, Brouard N, Williams B, et al,. Endogenous fibroblastic progenitor cells in the adult mouse lung are highly enriched in the sca-1 positive cell fraction. Stem Cells 2009; 27: 623-33.
56. McQualter JL, Yuen K, Williams B, et al,. Evidence of an epithelial stem/progenitor cell hierarchy in the adult mouse lung. Proc. Natl Acad. Sci. U. S. A. 2010; 107: 1414-19.
57. Hegab AE, Kubo H, Fujino N, et al,. Isolation and characterization of murine multipotent lung stem cells. Stem Cells Dev. 2010; 19: 523-35.
58. Dominici M, Le Blanc K, Mueller I, et al,. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 2006; 8: 315-17.
59. Hennrick KT, Keeton AG, Nanua S, et al,. Lung cells from neonates show a mesenchymal stem cell phenotype. Am. J. Respir. Crit. Care Med. 2007; 175: 1158-64.
60. Lama VN, Smith L, Badri L, et al,. Evidence for tissue-resident mesenchymal stem cells in human adult lung from studies of transplanted allografts. J. Clin. Invest. 2007; 117: 989-96.
61. Karoubi G, Cortes-Dericks L, Breyer I, et al,. Identification of mesenchymal stromal cells in human lung parenchyma capable of differentiating into aquaporin 5-expressing cells. Lab. Invest. 2009; 89: 1100-14.
62. Haynesworth SE, Baber MA, Caplan AI,. Cytokine expression by human marrow-derived mesenchymal progenitor cells in vitro: effects of dexamethasone and IL-1 alpha. J. Cell. Physiol. 1996; 166: 585-92.
63. Xu J, Woods CR, Mora AL, et al,. Prevention of endotoxin-induced systemic response by bone marrow-derived mesenchymal stem cells in mice. Am. J. Physiol. Lung Cell. Mol. Physiol. 2007; 293: L131-41.
64. Keating A,. Mesenchymal stromal cells. Curr. Opin. Hematol. 2006; 13: 419-25.
65. Spees JL, Olson SD, Whitney MJ, et al,. Mitochondrial transfer between cells can rescue aerobic respiration. Proc. Natl Acad. Sci. U. S. A. 2006; 103: 1283-8.
66. Prockop DJ,. 'Stemness' does not explain the repair of many tissues by mesenchymal stem/multipotent stromal cells (MSCs). Clin. Pharmacol. Ther. 2007; 82: 241-3.
67. Chang KT, Rajadurai VS, Walford NQ, et al,. Alveolar capillary dysplasia: absence of CD117 immunoreactivity of putative hemangioblast precursor cells. Fetal Pediatr. Pathol. 2008; 27: 127-40.
68. Suzuki T, Kubo H, Fujino N, et al,. Dynamic and multilineage expression of c-kit in developing human lungs. Am. J. Respir. Crit. Care Med. 2010; 181: A4898.
69. Lennartsson J, Jelacic T, Linnekin D, et al,. Normal and oncogenic forms of the receptor tyrosine kinase kit. Stem Cells 2005; 23: 16-43.
70. Ashman LK,. The biology of stem cell factor and its receptor C-kit. Int. J. Biochem. Cell Biol. 1999; 31: 1037-51.
71. Jin K, Mao XO, Sun Y, et al,. Stem cell factor stimulates neurogenesis in vitro and in vivo. J. Clin. Invest. 2002; 110: 311-19.
72. Messina E, De Angelis L, Frati G, et al,. Isolation and expansion of adult cardiac stem cells from human and murine heart. Circ. Res. 2004; 95: 911-21.
73. Castaldo C, Di Meglio F, Nurzynska D, et al,. CD117-positive cells in adult human heart are localized in the subepicardium, and their activation is associated with laminin-1 and alpha6 integrin expression. Stem Cells 2008; 26: 1723-31.
74. Weiss TS, Lichtenauer M, Kirchner S, et al,. Hepatic progenitor cells from adult human livers for cell transplantation. Gut 2008; 57: 1129-38.
75. Levina V, Marrangoni A, Wang T, et al,. Elimination of human lung cancer stem cells through targeting of the stem cell factor-c-kit autocrine signaling loop. Cancer Res. 2010; 70: 338-46.
76. Lindsey JY, Ganguly K, Brass DM, et al,. c-Kit is essential for alveolar maintenance and protection from emphysema-like disease in mice. Am. J. Respir. Crit. Care Med. 2011; 183: 1644-52.
77. Kajstura J, Rota M, Hall SR, et al,. Evidence for human lung stem cells. N. Engl. J. Med. 2011; 364: 1795-806.
78. Lung stem cells: looking beyond the hype. Nat. Med. 2011; 17: 788-9.
79. Anversa P, Kajstura J, Leri A, et al,. Tissue-specific adult stem cells in the human lung. Nat. Med. 2011; 17: 1038-9.
80. Suzuki T, Kondo T, Kubo H,. Evidence for human lung stem cells. N. Engl. J. Med. 2011; 365: 465.
81. Yamada M, Kubo H, Ishizawa K, et al,. Increased circulating endothelial progenitor cells in patients with bacterial pneumonia: evidence that bone marrow derived cells contribute to lung repair. Thorax 2005; 60: 410-13.
82. Burnham EL, Taylor WR, Quyyumi AA, et al,. Increased circulating endothelial progenitor cells are associated with survival in acute lung injury. Am. J. Respir. Crit. Care Med. 2005; 172: 854-60.
83. Yamada M, Kubo H, Kobayashi S, et al,. Bone marrow-derived progenitor cells are important for lung repair after lipopolysaccharide-induced lung injury. J. Immunol. 2004; 172: 1266-72.
84. Kubo H, Hegab AE, He M, et al,. Endogenous lung stem cells increased after lung injury. Proc. Am. Thorac. Soc. 2008; 5: 362-a-3.
85. Wong AP, Keating A, Lu WY, et al,. Identification of a bone marrow-derived epithelial-like population capable of repopulating injured mouse airway epithelium. J. Clin. Invest. 2009; 119: 336-48.
86. Thomson JA, Itskovitz-Eldor J, Shapiro SS, et al,. Embryonic stem cell lines derived from human blastocysts. Science 1998; 282: 1145-7.
87. Samadikuchaksaraei A, Cohen S, Isaac K, et al,. Derivation of distal airway epithelium from human embryonic stem cells. Tissue Eng. 2006; 12: 867-75.
88. Wang D, Haviland DL, Burns AR, et al,. A pure population of lung alveolar epithelial type II cells derived from human embryonic stem cells. Proc. Natl Acad. Sci. U. S. A. 2007; 104: 4449-54.
89. Rippon HJ, Lane S, Qin M, et al,. Embryonic stem cells as a source of pulmonary epithelium in vitro and in vivo. Proc. Am. Thorac. Soc. 2008; 5: 717-22.
90. Gadue P, Huber TL, Nostro MC, et al,. Germ layer induction from embryonic stem cells. Exp. Hematol. 2005; 33: 955-64.
91. Takahashi K, Tanabe K, Ohnuki M, et al,. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 2007; 131: 861-72.
92. Maekawa M, Yamaguchi K, Nakamura T, et al,. Direct reprogramming of somatic cells is promoted by maternal transcription factor Glis1. Nature 2011; 474: 225-9.
93. Somers A, Jean JC, Sommer CA, et al,. Generation of transgene-free lung disease-specific human induced pluripotent stem cells using a single excisable lentiviral stem cell cassette. Stem Cells 2010; 28: 1728-40.
94. Wetsel RA, Wang D, Calame DG,. Therapeutic potential of lung epithelial progenitor cells derived from embryonic and induced pluripotent stem cells. Annu. Rev. Med. 2011; 62: 95-105.
95. Wiwanitkit V,. CD133 and non-small-cell lung cancer. Eur. J. Cardiothorac Surg. 2010; 37: 988.
96. Moreira AL, Gonen M, Rekhtman N, et al,. Progenitor stem cell marker expression by pulmonary carcinomas. Mod. Pathol. 2010; 23: 889-95.
97. Moodley Y, Manuelpillai U, Weiss DJ,. Cellular therapies for lung disease: a distant horizon. Respirology 2011; 16: 223-37.
98. Fujino N, Kubo H, Ota C, et al,. A novel method for isolating individual cellular components from the adult human distal lung. Am. J. Respir. Cell Mol. Biol. 2011; doi:10.1165/2011-0172OC.
99. Roisin R,. Global strategy for the diagnosis, management and prevention of COPD updated 2009. 2009. [Accessed 28 Apr 2010.] Available from URL
100. Massaro GD, Massaro D,. Retinoic acid treatment abrogates elastase-induced pulmonary emphysema in rats. Nat. Med. 1997; 3: 675-7.
101. Matsuno H, Takei M, Hayashi H, et al,. Simvastatin enhances the regeneration of endothelial cells via VEGF secretion in injured arteries. J. Cardiovasc. Pharmacol. 2004; 43: 333-40.
102. Shigemura N, Okumura M, Mizuno S, et al,. Autologous transplantation of adipose tissue-derived stromal cells ameliorates pulmonary emphysema. Am. J. Transplant. 2006; 6: 2592-600.
103. Shigemura N, Okumura M, Mizuno S, et al,. Lung tissue engineering technique with adipose stromal cells improves surgical outcome for pulmonary emphysema. Am. J. Respir. Crit. Care Med. 2006; 174: 1199-205.
104. Fishman A, Martinez F, Naunheim K, et al,. A randomized trial comparing lung-volume-reduction surgery with medical therapy for severe emphysema. N. Engl. J. Med. 2003; 348: 2059-73.
105. Naunheim KS, Wood DE, Mohsenifar Z, et al,. Long-term follow-up of patients receiving lung-volume-reduction surgery versus medical therapy for severe emphysema by the National Emphysema Treatment Trial Research Group. Ann. Thorac. Surg. 2006; 82: 431-43.
106. Edwards MA, Hazelrigg S, Naunheim KS,. The National Emphysema Treatment Trial: summary and update. Thorac. Surg. Clin. 2009; 19: 169-85.